| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 976,225 | 848,744 | 750,443 | 534,906 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 848,744 | 750,443 | 534,906 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 381,243 | 621,966 | 614,116 | 714,432 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 243,196 | 226,778 | 136,327 | (179,526) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19,755) | (53,658) | 25,205 | 51,479 | | Earnings Before Interest And Taxes | 289,074 | 173,120 | 161,532 | (128,047) | | Interest Expense | 6,001 | 5,712 | 5,712 | 6,285 | | Income Before Tax | 283,073 | 167,408 | 155,820 | (134,332) | | Income Tax Expense | 2,205 | 8,818 | 9,490 | 2,179 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 280,868 | 158,590 | 146,330 | (136,511) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 280,868 | 158,590 | 146,330 | (136,511) | | Preferred Stock And Other Adjustments | (6,461) | (6,461) | (6,461) | (6,461) | | | Net Income Applicable To Common Shares | $274,407 | $152,129 | $139,869 | ($142,972) |
|
1.52% Nasdaq 0.00%
Income Statement
